Crossmark

Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings

Crossref DOI link: https://doi.org/10.1007/s12325-022-02219-w

Published Online: 2022-07-19

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wehkamp, Ulrike

Ardigò, Marco

Papadavid, Evangelia

Querfeld, Christiane

Nikbakht, Neda
Funding

Funding for this research was provided by:

Helsinn

Universitätsklinikum Schleswig-Holstein - Campus Kiel
License Information

Text and Data Mining valid from 2022-07-19

Version of Record valid from 2022-07-19
More Information

Article History

Received: 4 April 2022

Accepted: 8 June 2022

First Online: 19 July 2022

Change Date: 20 January 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s12325-022-02403-y

Updates are available Correction dated 2023-01-20

Click to view Correction: https://doi.org/10.1007/s12325-022-02403-y